Skip to main content

Table 1 Characteristics of survey respondents by study arm

From: The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial

Baseline characteristics

Overall

Clinic arm

Home arm

p-valuea

n (%)

n (%)

n (%)

All

445 (100)

209 (47.0)

236 (53.0)

 

Age group

   

0.480

  < 30

294 (66.1)

137 (65.6)

157 (66.5)

 30–39

111 (24.9)

54 (25.8)

57 (24.2)

 40–49

23 (5.2)

8 (3.8)

15 (6.4)

 50+

17 (3.8)

10 (4.8)

7 (3.0)

Risk group

   

0.491

 Women

150 (33.7)

71 (34.0)

79 (33.5)

 Heterosexual men

130 (29.2)

56 (26.8)

74 (31.4)

 MSM

165 (37.1)

82 (39.2)

83 (35.2)

Who they live with?

   

0.233

 Partner

65 (14.6)

31 (14.8)

34 (14.4)

 Friends / flatmates

237 (53.3)

109 (52.2)

128 (54.2)

 Parents

49 (11.0)

26 (12.4)

23 (9.7)

 Alone

82 (18.4)

41 (19.6)

41 (17.4)

 Other

12 (3.0)

2 (1.0)

10 (4.2)

Country of birth

   

0.870

 Australia

215 (54.8)

103 (55.4)

112 (54.4)

 Asia

48 (12.2)

22 (11.8)

26 (12.6)

 Europe

118 (30.1)

55 (29.6)

63 (30.6)

 Other

11 (2.9)

6 (3.2)

5 (2.4)

Previous CT diagnosis

   

0.841

 Yes

56 (12.6)

27 (12.9)

29 (12.3)

 No

389 (87.4)

182 (87.1)

207 (87.7)

Condom use in last 3 months (pre-diagnosis)

   

0.432

 Inconsistent (never/ sometimes)

333 (81.8)

162 (84.4)

171 (79.5)

 Consistent (always)

74 (18.2)

30 (15.6)

44 (20.5)

Number of sexual partners last 3 months

   

0.397

 0

26 (5.9)

10 (4.8)

16 (6.8)

 1

117 (26.3)

62 (29.8)

55 (23.3)

 2–5

221 (49.8)

101 (48.6)

120 (50.8)

  > 5

80 (18.0)

35 (16.8)

45 (19.1)

STI symptomsb at baseline

   

0.503

 Yes

196 (44.0)

96 (45.9)

100 (42.4)

 No

249 (56.0)

113 (54.1)

136 (57.6)

  1. Note: Data for some variables were not available for all participants
  2. MSM men who have sex with men, CT Chlamydia trachomatis
  3. aChi2 or Fisher’s exact test was used when appropriate
  4. bAnal and/or urogenital symptoms